My watch list
my.bionity.com  
Login  

219 Current news from israel

rss
matching the following criteria

Avilex Pharma receives Wellcome Trust Translation Award

09-Jun-2015

Avilex Pharma announces that it has received a 18 million DKK (2.4 million EUR) Translation Award from Wellcome Trust to fund the development of a novel drug candidate for acute treatment of ischemic stroke. Ischemic stroke is a leading cause of death and disability worldwide, with very few ...

more

Minervax initiates phase I clinical trial with Group B Streptococcal vaccine

04-Jun-2015

MinervaX, a privately held Danish biotech company, announced that the company has initiated a Phase I clinical trial with its Group B Streptococcal (GBS) vaccine candidate, GBS-NN, targeting pregnant women for the prevention of life-threatening infections in newborns. GBS is responsible for 50% ...

more

Infections can affect your IQ

New research shows that infections can impair your cognitive ability measured on an IQ scale

27-May-2015

New research shows that infections can impair your cognitive ability measured on an IQ scale. The study is the largest of its kind to date, and it shows a clear correlation between infection levels and impaired cognition. Anyone can suffer from an infection, for example in their stomach, urinary ...

more

CMC Biologics Expands GMP Manufacturing Capacity in the United States and Europe

Company plans to add more than 30,000L of bioreactor capacity across its three sites

11-May-2015

CMC Biologics, Inc announced a plan to expand its global manufacturing capacity by more than 30,000 liters in the United States and Europe to meet growing customer demands for late-stage and commercial manufacturing."This global expansion addresses increasing demands from our customers for ...

more

Ascendis Pharma A/S Announces Results of Phase 1 Study of TransCon Treprostinil

04-May-2015

Ascendis Pharma A/S announced that its Phase 1 single ascending dose study of TransCon Treprostinil produced dose-dependent increases in plasma treprostinil levels in-line with expectations. However, treprostinil-related injection-site tolerability issues did not meet the criteria defined in ...

more

Genmab Announces Phase III Study of Arzerra® Met Primary Endpoint of Improved Progression-Free Survival in Patients with Relapsed CLL

29-Apr-2015

Genmab A/S announced that the top-line results from the Phase III COMPLEMENT 2 study showed that treatment with Arzerra® (ofatumumab) plus fludarabine and cyclophosphamide met the primary endpoint of improved progression-free survival (PFS) in patients with relapsed CLL (p = 0.0036) compared to ...

more

Antibiotic Armageddon in UK and Europe by 2025

ESCMID warns that Europe may surpass one million deaths due to ineffective antibiotics by 2025

23-Apr-2015

The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organization that explores risk assessment, knowledge sharing and best practices in the fight against infectious disease – has warned that Britain and Europe collectively could face more than a million deaths in an ...

more

Vaccine against Placental Malaria is ready to start human tests

24-Mar-2015

ExpreS2ion Biotechnologies announced the release by its partners at University of Copenhagen, of a vaccine candidate against the form of malaria that strikes pregnant women, for testing in humans. The vaccine candidate contains a malaria antigen made with ExpreS2ion’s proprietary protein ...

more

Genmab Acquires Antibody Assets from iDD Biotech

20-Mar-2015

Genmab A/S announced that its subsidiary Genmab Holding B.V. entered into an agreement to purchase antibodies and related patents and know-how from iDD Biotech SAS. The pre-clinical stage antibodies are directed to DR5, also known as Trail Receptor 2 (TRAIL-R2), an emerging cancer target. ...

more

Recipharm appoints new position of Vice President Quality Management

11-Mar-2015

Recipharm announced that it has appointed Thomas Beck to the new senior role of Vice President Quality Management (VP QM) with effect from 1st April 2015. Thomas is currently Head of Quality Control and Assurance at Recipharm Stockholm, a position that he has held since 2010. He is also Chairman ...

more

Page 1 From 22
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE